In the inaugural episode of the CIP-Net Podcast, Drs. Bodour Salhia of University of Southern California and Robert Samstein of Icahn School of Medicine at Mount Sinai explore the emerging field of cancer immunoprevention—using the immune system to recognize and eliminate cancer at its earliest stages. They discuss why prevention may offer unique advantages over treating established cancer, who may benefit most from immunoprevention strategies, and the opportunities and challenges of translating this science into clinical practice.
The conversation also examines the importance of patient perspectives, long-term NCI support, and collaboration through CIP-Net in moving cancer prevention research forward—from understanding early cancer development to ultimately intercepting cancer before it becomes clinically detectable.